Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCSK9 inhibition for postprandial lipemia and inflammation in men with type 2 diabetes mellitus
NL-OMON22535Phase 4Active, not recruiting
- Sponsor
- Franciscus Gasthuis & Vlietland
- Start
- Nov 2017
- Countries
- 1
01
Overview
Phase 4 trial, sponsored by Franciscus Gasthuis & Vlietland. Started Nov 2017; status: active, not recruiting.
Beyond the preview
Go deeper on NL-OMON22535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON22535.